Boiron Faces New False Ad Suit Over Homeopathic Flu Drug

Law360, New York (September 11, 2013, 5:12 PM ET) -- A plaintiff who opted out of a proposed $12 million false advertising class settlement with homeopathic medicine maker Boiron Inc. launched a separate suit Monday in California state court alleging the company deceptively advertised its Oscillococcinum homeopathic remedy as capable of relieving flu-like symptoms.

Plaintiff Leonidas Jovel alleges Boiron’s false misrepresentations of the health benefits of Oscillo deceived consumers into paying a premium for Oscillo — which can cost between $12 and $20 a box and is available in six, 12 or 30 dosages — knowing...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required